KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Teladoc Health (TDOC) over the last 12 years, with Q3 2025 value amounting to $29.0 million.

  • Teladoc Health's Capital Expenditures fell 173.6% to $29.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $110.4 million, marking a year-over-year decrease of 1159.68%. This contributed to the annual value of $113.3 million for FY2024, which is 2182.57% down from last year.
  • Teladoc Health's Capital Expenditures amounted to $29.0 million in Q3 2025, which was down 173.6% from $29.0 million recorded in Q2 2025.
  • In the past 5 years, Teladoc Health's Capital Expenditures registered a high of $47.7 million during Q4 2022, and its lowest value of $10.4 million during Q2 2021.
  • Over the past 5 years, Teladoc Health's median Capital Expenditures value was $29.0 million (recorded in 2025), while the average stood at $29.3 million.
  • In the last 5 years, Teladoc Health's Capital Expenditures soared by 46683.62% in 2021 and then plummeted by 3302.0% in 2024.
  • Quarter analysis of 5 years shows Teladoc Health's Capital Expenditures stood at $20.0 million in 2021, then surged by 138.5% to $47.7 million in 2022, then fell by 26.4% to $35.1 million in 2023, then plummeted by 33.02% to $23.5 million in 2024, then grew by 23.5% to $29.0 million in 2025.
  • Its Capital Expenditures was $29.0 million in Q3 2025, compared to $29.0 million in Q2 2025 and $28.9 million in Q1 2025.